Your browser doesn't support javascript.
loading
Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenib.
Casadei-Gardini, Andrea; Rovesti, Giulia; Dadduzio, Vincenzo; Vivaldi, Caterina; Lai, Eleonora; Lonardi, Sara; Fornaro, Lorenzo; Pretta, Andrea; Zagonel, Vittorina; Bernardini, Laura; Astara, Giorgio; D'Amico, Francesco E; Masi, Gianluca; Rimini, Margherita; Scartozzi, Mario; Cascinu, Stefano.
Afiliação
  • Casadei-Gardini A; Department of Medical Oncology, Università Vita-Salute, San Raffaele Hospital IRCCS, 20019, Milan, Italy. Electronic address: casadeigardini@gmail.com.
  • Rovesti G; Department of Oncology and Hematology, Division of Oncology, University of Modena and Reggio Emilia, 4121, Modena, Italy.
  • Dadduzio V; Medical Oncology Unit 1, Veneto Institute of Oncology IRCCS, Padua, Italy.
  • Vivaldi C; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via savi 10, 56126, Pisa PI, Italy.
  • Lai E; Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy.
  • Lonardi S; Medical Oncology Unit 1, Veneto Institute of Oncology IRCCS, Padua, Italy.
  • Fornaro L; U.O. Oncologia Medica 2 Universitaria, Azienda Ospedaliero-Universitaria Pisana, via Roma 67, 56126 Pisa, Italy.
  • Pretta A; Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy.
  • Zagonel V; Medical Oncology Unit 1, Veneto Institute of Oncology IRCCS, Padua, Italy.
  • Bernardini L; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via savi 10, 56126, Pisa PI, Italy.
  • Astara G; Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy.
  • D'Amico FE; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
  • Masi G; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via savi 10, 56126, Pisa PI, Italy.
  • Rimini M; Department of Oncology and Hematology, Division of Oncology, University of Modena and Reggio Emilia, 4121, Modena, Italy.
  • Scartozzi M; Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy.
  • Cascinu S; Department of Medical Oncology, Università Vita-Salute, San Raffaele Hospital IRCCS, 20019, Milan, Italy.
HPB (Oxford) ; 23(6): 915-920, 2021 06.
Article em En | MEDLINE | ID: mdl-33191108
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: HPB (Oxford) Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: HPB (Oxford) Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido